Laurion Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-522,929
| Closed | -$47.6M | – | 251 |
|
|
2023
Q2 | $47.6M | Buy |
522,929
+148,590
| +40% | +$13.5M | 0.27% | 15 |
|
|
2023
Q1 | $24.7M | Buy |
+374,339
| New | +$24.7M | 0.17% | 22 |
|
|
2022
Q2 | – | Sell |
-22,000
| Closed | -$1.12M | – | 353 |
|
|
2022
Q1 | $1.12M | Buy |
+22,000
| New | +$1.12M | 0.01% | 135 |
|
|
2018
Q1 | – | Sell |
-50,000
| Closed | -$1.09M | – | 1021 |
|
|
2017
Q4 | $1.09M | Buy |
+50,000
| New | +$1.09M | 0.01% | 563 |
|